TXMD - TherapeuticsMD, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
TherapeuticsMD, Inc.
TherapeuticsMD Inc is a women's health care company focused on creating and commercializing products targeted exclusively for women. It is engaged in pre-commercialization activities for advanced hormone therapy pharmaceutical product.
IPO Date: October 31, 2011
Sector: Healthcare
Industry: Pharma
Market Cap: $23.15M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.14 | 3.78%
Avg Daily Range (30 D): $0.05 | 2.05%
Avg Daily Range (90 D): $0.05 | 2.49%
Institutional Daily Volume
Avg Daily Volume: 2.11M
Avg Daily Volume (30 D): .02M
Avg Daily Volume (90 D): .03M
Trade Size
Avg Trade Size (Sh.): 294
Avg Trade Size (Sh.) (30 D): 145
Avg Trade Size (Sh.) (90 D): 190
Institutional Trades
Total Institutional Trades: 1,122
Avg Institutional Trade: $1.43M
Avg Institutional Trade (30 D): $2.37M
Avg Institutional Trade (90 D): $2.37M
Avg Institutional Trade Volume: .01M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.56M
Avg Closing Trade (30 D): $M
Avg Closing Trade (90 D): $M
Avg Closing Volume: 10.79K
 
News
Oct 3, 2024 @ 12:30 PM
Sexual Wellness Market to Witness 4.7% CAGR by 203...
Source: Globe Newswire
Apr 14, 2023 @ 4:00 PM
All You Need to Know About TherapeuticsMD (TXMD) R...
Source: Zacks Equity Research
Nov 15, 2022 @ 12:55 AM
TherapeuticsMD (TXMD) Reports Q3 Loss, Lags Revenu...
Source: Zacks Equity Research
Nov 9, 2022 @ 10:45 PM
Organogenesis (ORGO) Lags Q3 Earnings and Revenue ...
Source: Zacks Equity Research
Sep 7, 2022 @ 9:16 AM
Why Allena Pharmaceuticals Tumbled Over 30%; Here ...
Source: Lisa Levin
Financials
  TTM Q1 2026 Q4 2025
Basic EPS $.01 $.01 $-.05
Diluted EPS $.01 $.01 $-.05
Revenue $.87M $.72M $.89M
Gross Profit
Net Income / Loss $.16M $.1M $-.62M
Operating Income / Loss $-.82M $-.72M $-1.55M
Cost of Revenue
Net Cash Flow $.77M $.94M $.37M
PE Ratio    
Splits
May 09, 2022 1:50
Oct 03, 2011 1:100
Jul 27, 2009 3:1